Primary lymphoma of the central nervous sytem. A report of 20 cases and a review of the literature

T. H. Grote, W. W. Grosh, A. F. List, R. Wiley, J. B. Cousar, D. H. Johnson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Twenty patients with primary non-Hodgkin's lymphoma of the central nervous system (CNS) were seen at Vanderbilt and its affiliated hospitals between 1974 and 1986. Histologically, the most common subtypes were large, noncleaved cell lymphoma and immunoblastic lymphoma of B cells. However, multiple histologies were identified. Lesions most commonly involved the frontal lobes and/or deep nuclei. Positive cerebrospinal fluid cytology was rare at initial presentation. Seventeen patients were treated with surgical biopsy or resection followed by whole brain radiotherapy at a median dose of 5,000 cGy (range: 3,000-5,600 cGy). Seven patients have been followed for less than 12 months since diagnosis. Of the remaining patients, 7 (54%) survived at least 1 year. The extent of surgery performed, dose of radiotherapy administered, subclass of lymphoma diagnosed, or location(s) of involvement within the CNS did not influence survival. Treatment rarely caused a dramatic improvement in performance status despite objective signs of response. New treatment strategies are needed to improve the management of these tumors.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume12
Issue number2
StatePublished - 1989

Fingerprint

Lymphoma
Large-Cell Immunoblastic Lymphoma
Radiotherapy
Central Nervous System
Frontal Lobe
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Cell Biology
Cerebrospinal Fluid
Histology
Biopsy
Survival
Brain
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Primary lymphoma of the central nervous sytem. A report of 20 cases and a review of the literature. / Grote, T. H.; Grosh, W. W.; List, A. F.; Wiley, R.; Cousar, J. B.; Johnson, D. H.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 12, No. 2, 1989, p. 93-100.

Research output: Contribution to journalArticle

@article{1083c91c6259415a8f34393d046481ce,
title = "Primary lymphoma of the central nervous sytem. A report of 20 cases and a review of the literature",
abstract = "Twenty patients with primary non-Hodgkin's lymphoma of the central nervous system (CNS) were seen at Vanderbilt and its affiliated hospitals between 1974 and 1986. Histologically, the most common subtypes were large, noncleaved cell lymphoma and immunoblastic lymphoma of B cells. However, multiple histologies were identified. Lesions most commonly involved the frontal lobes and/or deep nuclei. Positive cerebrospinal fluid cytology was rare at initial presentation. Seventeen patients were treated with surgical biopsy or resection followed by whole brain radiotherapy at a median dose of 5,000 cGy (range: 3,000-5,600 cGy). Seven patients have been followed for less than 12 months since diagnosis. Of the remaining patients, 7 (54{\%}) survived at least 1 year. The extent of surgery performed, dose of radiotherapy administered, subclass of lymphoma diagnosed, or location(s) of involvement within the CNS did not influence survival. Treatment rarely caused a dramatic improvement in performance status despite objective signs of response. New treatment strategies are needed to improve the management of these tumors.",
author = "Grote, {T. H.} and Grosh, {W. W.} and List, {A. F.} and R. Wiley and Cousar, {J. B.} and Johnson, {D. H.}",
year = "1989",
language = "English (US)",
volume = "12",
pages = "93--100",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Primary lymphoma of the central nervous sytem. A report of 20 cases and a review of the literature

AU - Grote, T. H.

AU - Grosh, W. W.

AU - List, A. F.

AU - Wiley, R.

AU - Cousar, J. B.

AU - Johnson, D. H.

PY - 1989

Y1 - 1989

N2 - Twenty patients with primary non-Hodgkin's lymphoma of the central nervous system (CNS) were seen at Vanderbilt and its affiliated hospitals between 1974 and 1986. Histologically, the most common subtypes were large, noncleaved cell lymphoma and immunoblastic lymphoma of B cells. However, multiple histologies were identified. Lesions most commonly involved the frontal lobes and/or deep nuclei. Positive cerebrospinal fluid cytology was rare at initial presentation. Seventeen patients were treated with surgical biopsy or resection followed by whole brain radiotherapy at a median dose of 5,000 cGy (range: 3,000-5,600 cGy). Seven patients have been followed for less than 12 months since diagnosis. Of the remaining patients, 7 (54%) survived at least 1 year. The extent of surgery performed, dose of radiotherapy administered, subclass of lymphoma diagnosed, or location(s) of involvement within the CNS did not influence survival. Treatment rarely caused a dramatic improvement in performance status despite objective signs of response. New treatment strategies are needed to improve the management of these tumors.

AB - Twenty patients with primary non-Hodgkin's lymphoma of the central nervous system (CNS) were seen at Vanderbilt and its affiliated hospitals between 1974 and 1986. Histologically, the most common subtypes were large, noncleaved cell lymphoma and immunoblastic lymphoma of B cells. However, multiple histologies were identified. Lesions most commonly involved the frontal lobes and/or deep nuclei. Positive cerebrospinal fluid cytology was rare at initial presentation. Seventeen patients were treated with surgical biopsy or resection followed by whole brain radiotherapy at a median dose of 5,000 cGy (range: 3,000-5,600 cGy). Seven patients have been followed for less than 12 months since diagnosis. Of the remaining patients, 7 (54%) survived at least 1 year. The extent of surgery performed, dose of radiotherapy administered, subclass of lymphoma diagnosed, or location(s) of involvement within the CNS did not influence survival. Treatment rarely caused a dramatic improvement in performance status despite objective signs of response. New treatment strategies are needed to improve the management of these tumors.

UR - http://www.scopus.com/inward/record.url?scp=0024522020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024522020&partnerID=8YFLogxK

M3 - Article

C2 - 2650529

AN - SCOPUS:0024522020

VL - 12

SP - 93

EP - 100

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 2

ER -